Can you talk to us about what was learned?

Yes, this was a very interesting trial presented by a colleague from China.

So this is a cluster randomized design, so they assigned the whole villages.

They invested a lot of effort into training the GPs, nurses, and everybody else.

And then the trial went on for four years.

And during these four years, they saw remarkable reduction of blood pressure.

So this year they reported a seven-year follow-up of this study.

So what are some of the highlights or important messages for you from these new heart failure guidelines?

What should attendees focus on? What shouldn't they miss?

Briefly about the AI, which Tom has already expanded upon and talked about.

One of the key elements is that we don't look at AI as some sort of a future elusive promise ahead of us.

We actually look and identify within the program tools and aspects in which AI is already with us.

It's a choice that we have to make.

in the ECG interpretation, imaging, risk stratification and other approaches.

And what we want to show during the Congress is how AI can serve as a co-pilot.

You want to talk about the medalist, the gold medalist?